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Abstract
The cellular environment of the mammalian heart constantly is challenged with environmental and 
intrinsic pathological insults, which affect the proper folding of proteins in heart failure. The 
effects of damaged or misfolded proteins on the cell can be profound and result in a process 
termed “proteotoxicity”. While proteotoxicity is best known for its role in mediating the 
pathogenesis of neurodegenerative diseases such as Alzheimer’s disease, its role in human heart 
failure also has been recognized. The UPR involves three branches, including PERK, ATF6, and 
IRE1. In the presence of a misfolded protein, the GRP78 molecular chaperone that normally 
interacts with the receptors PERK, ATF6, and IRE-1 in the endoplasmic reticulum detaches to 
attempt to stabilize the protein. Mouse models of cardiac hypertrophy, ischemia, and heart failure 
demonstrate increases in activity of all three branches after removing GRP78 from these internal 
receptors. Recent studies have linked elevated PERK and CHOP in vitro with regulation of ion 
channels linked with human systolic heart failure. With this in mind, we specifically investigated 
ventricular myocardium from 10 patients with a history of conduction system defects or 
arrhythmias for expression of UPR and autophagy genes compared to myocardium from non-
failing controls. We identified elevated Chop, Atf3, and Grp78 mRNA, along with XBP-1-
regulated Cebpa mRNA, indicative of activation of the UPR in human heart failure with 
arrhythmias.
Address correspondence to: Dr. Monte S Willis, Department of Pathology and Laboratory Medicine, Medical Biomolecular 
Research Building, Room 2336, Campus Box #7527, Chapel Hill, NC 27599, USA. monte_willis@med.unc.edu.
*Equal contributors.
Disclosure of conflict of interest
None.
HHS Public Access
Author manuscript
Int J Clin Exp Med. Author manuscript; available in PMC 2017 August 07.
Published in final edited form as:
Int J Clin Exp Med. 2017 ; 10(1): 1051–1058.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Keywords
Heart failure; unfolded protein response; GRP78; IRE-1; CHOP
Introduction
The cellular environment of the mammalian heart constantly is challenged with 
environmental and intrinsic pathological insults, which affect the proper folding of proteins 
in human heart failure [1]. The effects of damaged or misfolded proteins on the cell can be 
profound and result in a process termed “proteotoxicity”. While proteotoxicity is best known 
for its role in mediating the pathogenesis of neurodegenerative diseases such as Alzheimer’s 
disease, its role in human heart failure also has been recognized [2]. Of note, both exercise 
[3] and direct induction of autophagy [4] experimentally attenuate both the accumulation of 
soluble misfolded pre-amyloid oligomers and the heart failure it induces [5, 6].
The unfolded protein response (UPR) has been studied extensively in diabetes and 
neurological diseases as a response to the presence and/or accumulation of damaged proteins 
in the endoplasmic reticulum. The UPR stress response is highly conserved from yeast to 
mammalian cells and has a protective role in cell survival by eliminating misfolded proteins. 
However, when its activation is prolonged, the UPR can induce cell dysfunction and death 
[7]. In the heart, the UPR is not well understood and has been implicated in both protecting 
and impairing heart function in experimental systems [7].
The UPR involves three branches, each with distinct signaling pathways that enhance 
protein folding or attenuate protein synthesis and loading of the endoplasmic reticulum (1) 
PERK; (2) ATF6; and (3) IRE1 [8]. In the presence of a misfolded protein, the GRP78 
molecular chaperone that normally interacts with the receptors PERK, ATF6, and IRE-1 in 
the endoplasmic reticulum detaches to attempt to stabilize the protein [8]. Activation of 
PERK, ATF6, and IRE-1 occurs upon removal of GRP78. In mouse models of cardiac 
hypertrophy [9–11], ischemia [12, 13], and heart failure [10, 14], elevations in all three UPR 
pathways have been reported. In human failing heart tissue, elevated PERK and down-
stream CHOP mRNA has been reported from 3 human heart failure samples [15], with 
elevated spliced variant XBP1 and downstream GRP78 proteins levels reported in 4 human 
dilated and ischemic cardiomyopathy samples [16]. Interestingly, the identification of 
elevated PERK and CHOP led to in vitro studies linking PERK activation to SCN5a and 
Kv4.3 mRNA levels, implicating a link to the sodium current in human systolic heart failure. 
Systolic heart failure greatly increases susceptibility to arrhythmias, and ventricular 
arrhythmia is a common cause of death in heart failure patients. With this in mind, we 
specifically investigated ventricular myocardium from 10 patients with a history of 
conduction system defects or arrhythmias for expression of UPR and autophagy genes 
compared to myocardium from non-failing controls.
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Methods
Human heart failure samples and institutional review board (IRB) approval
Human samples are from subjects consented and collected for future research by the Duke 
Human Heart Repository (Pro00005621). A “Request for Waiver or Alteration of Consent 
and HIPAA Authorization” was submitted to the Duke IRB for the present study 
(Pro00060625) and approved (19 February 2015). In parallel, a request for “Exemption from 
IRB Review” was submitted to the University of North Carolina IRB for the present studies 
to be performed at UNC (14-3334) and approved (10 March 2015). Heart failure samples 
were de-identified without PHI and collected from heart transplant recipients at the time of 
transplant. Non- failing control samples were obtained from organ donors whose hearts were 
not used for transplant. De-identified heart samples were chosen based on the presence of 
cardiac conduction system abnormality or arrhythmia, which included prolonged QT, right 
or left bundle branch block, ventricular tachycardia, and other dysrhythmias, as indicated in 
Table 2.
RNA isolation and qRT-PCR analysis of mRNA
Cardiac tissues were homogenized using a TissueLyser LT (Qiagen N.V. #69980, Venlo, The 
Netherlands) according to the manufacturer’s protocols. Approximately 20–40 mg of apical 
ventricle was homogenized in 1 mL of Trizol (Life Technologies #15596-026, Carlsbad, 
CA) using a 5-mm stainless steel bead (Qiagen N.V. #69989). Chloroform (200 μL) was 
added, centrifuged at 12,000 g (15 min at 4°C), isopropanol (0.5 mL) was then added to the 
aqueous phase, centrifuged at 12,000 g (10 min at 4°C), and the resulting RNA pellet was 
washed with 1 mL of 75% ethanol, then centrifuged at 7500 g (5 min at 4°C). The resulting 
pellet was dried and resuspended in RNase-free water. RNA concentrations were then 
determined by UV spectroscopy (absorbance of 260–280 nm). RNAs (500 ng) were reverse-
transcribed using iScript reverse transcription supermix (Bio-Rad Laboratories #170-8841, 
Hercules, CA). TaqMan gene expression assays were performed using universal TaqMan 
master mix (Life Technologies #4304437) using the fourteen primer pairs shown in Table 1.
Statistical analysis
SigmaPlot (Systat Software, Inc., San Jose, CA) was used to determine significant statistical 
difference by Student’s t-test. A P value < 0.05 was considered significant.
Results
The unfolded protein response (UPR) includes signaling by IRE-1, PERK, and ATF6 that 
are activated when misfolded proteins displace GRP78 from these receptors in the 
endoplasmic reticulum [17, 18]. We investigated how IRE-1 signaling was affected by 
measuring spliced Xbp-1 [18] and the XBP-1 regulated expression of the C/EBP (Cebpa) 
gene expression [19]. Compared to non-failing human heart controls, samples from human 
heart failure patients did not have increased spliced Xbp-1 mRNA (Figure 1A). However, 
significant increases in hCebpa mRNA were identified (Figure 2B), consistent with 
increased IRE-1 pathway signaling. The relationship between XBP1 and C/EBPb (Cebpb) is 
a bit more complex, with evidence that C/EBPb induces expression of XBP1 protein [19]. 
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The heart failure samples did not demonstrate any differences in hCebpb mRNA from 
controls (Figure 2B).
The stress caused in the ER by the presence of unfolded proteins can also cause signaling 
through PERK, whereby PERK proteins dimerize and undergo autophosphorylation [20]. 
This autophosphorylation leads to downstream phosphorylation of eIF2 and elevations in 
CHOP expression by qRT-PCR [21]. We identified significant increases in both Chop and 
Atf3 mRNA in the human heart failure samples (Figure 1C). Activation of ATF4 increases 
target gene expression, including the transcription factor CHOP (CCAAT/-enhancer-binding 
protein homologous protein) [22], which itself induces the expression of Atf3 mRNA [23]. 
While activation of ATF6 signaling was not directly measured, due largely to the 
deficiencies in reliable reagents [22], we determined the mRNA levels of other reported 
genes involved in the UPR. We identified significant increases in Grp78 (Figure 1D), likely 
reflecting compensatory upregulation in response to the clear activation of GRP78 and 
IRE-1 signaling [22]. In summary, the significant increases in Cebpa, Chop, Atf3, and Grp78 
mRNA seen in human heart failure provide evidence for activation of the IRE-1 and PERK 
signaling pathways.
In neurodegenerative diseases (e.g. Alzheimer Disease’s) increases in autophagy ameliorate 
endoplasmic reticulum stress and the UPR by eliminating misfolded proteins [24]. Both 
abnormal UPR and impaired autophagy have been implicated in the heart experimentally 
and are important complementary systems for reacting to misfolded proteins [25]. We 
therefore investigated the transcriptional regulation of autophagy in these failing human 
hearts. Central to the regulation of autophagy in heart disease, the Beclin 1 protein functions 
as a scaffolding protein assembling the Beclin interactome to regulate Class II PI3K/VPS34 
activity, which tightly controls autophagy at multiple stages [26]. Autophagy is also 
regulated at the transcriptional level: increased Atg5, Atg7, Atg12, Bnip3, and Vps34 
mRNA enhance autophagy [27]. RT-qPCR analysis of these genes in human heart failure 
identified significantly increased Beclin1 and Vps34 mRNA (Figure 2A), along with 
increased Atg5 and Atg7 mRNA (Figure 2B), consistent with increased autophagy.
Discussion
Recent studies have identified the presence of non-functional sodium channels (SCN5A) in 
heart failure patients, which then get trapped in the endoplasmic reticulum and activate the 
UPR [15]. Induction of SCN5a variants by angiotensin II or hypoxia activates the UPR to 
down-regulate the Na+ channel activity, all of which is prevented by inhibiting PERK [15], 
demonstrating the causal relationship between these SCN5a variants, the UPR, and Na+ 
channel activity. The activation of the UPR has been reported in dilated (n=21) and ischemic 
cardiomyopathy patients (n=21) compared to non-failing control hearts, including increases 
in GRP78, XBP1, and ATF6 [28]. Other studies have identified increases in PERK and 
CHOP protein levels along with increased mRNA of proteins involved in IRE-1 (increased 
Cebpa) and CHOP (Chop, Atf3) in heart failure patients (n=3) [15]. Given the close 
relationship between arrhythmias and the UPR, we interrogated myocardium from heart 
failure patients with arrhythmias to determine activation of the UPR in the current study. We 
identified significant increases in myocardial Cebpa, Chop, Atf3, and Grp78 mRNA in 
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human heart failure providing evidence for activation of the IRE-1 and PERK signaling 
pathways. In addition, we identified evidence for increases in autophagy in tissue from these 
patients. Conclusive demonstration of autophagic flux is essentially impossible in human 
tissue, but these transcriptional changes confirm that the autophagic signaling pathway is 
intact and active.
The relationship between endoplasmic reticulum stress, activation of the UPR, and 
autophagy has been described experimentally to be a form of cardioprotection. In previous 
studies, drugs routinely given to induce the UPR (tunicamycin and thapsigargin) were given 
at varying doses prior to ischemia-reperfusion injury using a working heart preparation (30 
min ischemia followed by 2 hours reperfusion) [29]. These studies found that lower doses of 
tunicamycin and thapsigargin led to autophagy and induction of GRP78, and were 
associated with improved function, reduced infarct size, and decreased apoptosis after 
ischemia-reperfusion [29]. These studies demonstrated the proof of concept that induction of 
autophagy by endoplasmic reticulum stress may enhance the cardiac response to injury. In 
the context of human heart failure, the induction of the UPR and autophagy in this study of 
samples from end-stage human heart failure patients may represent attempts at 
cardioprotection after chronic extreme injury.
Cardiac insults, including oxidized proteins, induce the UPR, which includes the 
endoplasmic reticulum chaperone protein GRP78 [30]. GRP78 is found in the endoplasmic/
sarcoplasmic reticulum bound to PERK, IRE1, and ATF6 receptors to prevent their 
activation of the UPR [21]. In the presence of unfolded proteins, GRP78 preferentially shifts 
to these proteins to stabilize their conformation, leaving PERK, IRE1, and ATF6 to regulate 
survival and apoptotic signaling downstream [21]. Previous studies have suggested that 
endoplasmic reticulum stress may be a therapeutic target in heart disease, as XBP-1 
mediated induction of endoplasmic reticulum chaperones occurs in ischemia reperfusion 
injury and PERK/CHOP transmits pro-apoptotic signaling [31]. However, their regulation in 
heart failure has been described in humans only experimentally with increased SERCA 
expression [32].
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Figure 1. 
Transcriptional regulation of the unfolded protein response in human heart failure. qRT-PCR 
analysis of genes involved in the unfolded protein response normalized to Gapdh in 
ventricular myocardium from patients with conduction defects or arrhythmias (n=10) and 
control healthy hearts (n=5). Patients’ clinical data are detailed in Table 2. Data are 
presented as means ± SEM with significant differences indicated (*, P < 0.05).
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Figure 2. 
QRT-PCR analysis of autophagy genes in human heart failure. qRT-PCR analysis of genes 
involved in autophagy normalized to Gapdh in ventricular myocardium from patients with 
conduction defects or arrhythmias (n=10) and control healthy hearts (n=5). Patients’ clinical 
data are detailed in Table 2. Data are presented as means ± SEM with significant differences 
indicated (*, P < 0.05).
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Table 1
Primer Probe sets used on human heart samples
QRT-PCR Primer and Probe sets (human):
Atg5
  Forward: CAA GAA GAC ATT AGT GAG ATA TGG
  Reverse: GCA AGA AGA TCA AAT AGC AAA CC
  Probe: FAT ATG AAG GCA CAC CAC TGA AAT GGC AQ
Atg7
  Forward: AGC AGC AGT GAC GAT CGG AT
  Reverse: CGT GAA AGA AAT CCC CGG AT
  Probe: FTG AGC CTC CAA CCT CTC TTG GGC Q
Atg12
  Forward: TAT GTG AAT CAG TCC TTT GCT C
  Reverse: CCA GTT TAC CAT CAC TGC CA
  Probe: FTC CCC AGA CCA AGA AGT TGG AAC TCQ
Beclin1
  Forward: GCA TAT GGC ATG ATA GCC TC
  Reverse: TCC ACA TGG CAT TAA TCT CCT
  Probe: FAT CAC CAG TAT CTT CAG CCC CAG GQ
Vps34
  Forward: GCA CTT GAA CCA GAT AAA ACT GT
  Reverse: GCA TGT AAT GCA CAG CCT CT
  Probe: FTC CGA CAG GTC TAA GCG GAA TTT ATC CQ
Gabarapl1
  Forward: GAC GCC TTA TTC TTC TTT GTC A
  Reverse: CTC ATG ATT GTC CTC ATA CAG
  Probe: FAC CAT CCC TCC CAC CAG TGC TAC CAQ
Grp78
  Forward: GCT TCT GAT AAT CAA CCA ACT G
  Reverse: TGT ACC CAG AAG ATG ATT GTC
  Probe: FAG GTC TAT GAA GGT GAA AGA CCC CTG Q
Xbp-1 Spliced
  Forward: GAA GAG GAG GCG GAA GCC AA
  Reverse: GCC TGC ACC TGA CTC AGC A
Xbp-1 Full
  Forward: GAA GAG GAG GCG GAA GCC AA
  Reverse: TAG TCT GAG TGC TGC GGA CT
  Probe: FAC CCG GCC ACT GGC CTC ACT TCA Q
Cebpa
  Forward: AGG CTC GCC ATG CCG GGA
  Reverse: GCT CCG CCT CGT AGA AGT
  Probe: FAC TCT AAC TCC CCC ATG GAG TCG GQ
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QRT-PCR Primer and Probe sets (human):
Cebpb
  Forward: ATA AAT AAC CGG GCT CAG GAG
  Reverse: CCT CGG GTG GGT CCC CTT
  Probe: FTT AGC GAG TCA GAG CCG CGC ACG Q
Chop
  Forward: CTG GAA ATG AAG AGG AAG AAT C
  Reverse: TGG TTC TGG CTC CTC CTC A
  Probe: FTC ACC ACT CTT GAC CCT GCT TCT CTG Q
Atf3
  Forward: TGC CTG CAG AAA GAG TCG GA
  Reverse: CTT CTC GTT CTT GAG CTC CT
  Probe: FCT GAG CCT TCA GTT CAG CAT TCA CAC Q
Gapdh
  Forward: ACC TCA ACT ACA TGG TTT AC
  Reverse: GAA GAT GGT GAT GGG ATT TC
  Probe: FCA AGC TTC CCG TTC TCA GCC Q
F: 5’-Fluorescein (FAM); Q: Quencher (TAMRA). The method for RNA isolation and Real-time RT-PCR was described in Kim et al, 2002 PNAS 
99: 4602–4607.
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Table 2
Patient clinical characteristics with arrhythmia description
Group Age Sex Clinical Characteristics Arrhythmia
NonF 1 66 F Cerebral aneurysm; nonsmoker; not diabetic; heart normal size; BMI=24 None
NonF 2 54 F EF=55%; no hypertrophy; nonsmoker; nondiabetic; BMI=30 None
NonF 3 25 M HTN; ICH/stroke None
NonF 4 62 M HTN; ICH/stroke None
NonF 5 36 M EF=55% None
HF 1 59 M s/p CABG; pulmonary edema; NIDDM; HTN; CAD Prolonged QT
HF 2 62 F ICM; CAD; HTN; s/p ICD; s/p IABP; smoker; anterior STEMI w/ occlusion of proximal LAD; 
COPD
Bradycardia
HF 3 58 M EF 10%; DCM; COPD; CAD; PE; s/p ICD; NIDDM; previous MI; s/p RVAD; ex-smoker; 
cardiac arrest
LBBB; VF
HF 4 75 F ICM; Acute MI with cardiogenic shock (NSTEMI); NYHA Class IV; s/p ECMO; IDDM; acute 
renal failure
RBBB
HF 5 61 M EF 15%; NICM; diabetes DM2 (NIDDM); HTN; CAD; Cardiogenic shock; CKD; former 
smoker (quit 1994); COPD; NYHA Class IV; s/p ICD; atrial fibrillation
AF; NSVT
HF 6 57 M EF 15-20%; NICM; s/p IABP; traumatic brain injury; HTN; hypercalcemia; obese; OSA; 
hyponatremia; cardiogenic shock; s/p ICD; pulmonary HTN; former smoker
AF; Dysrhythmias
HF 7 64 M NICM; s/p LVAD; HTN; Mitral valve disorder; ICD; former smoker; non-diabetic; BMI=26 Paroxysmal VT
HF 8 61 M EF < 15%; ICM; NSTEMI; s/p IABP; s/p ICD; CAD; PVD; BMI=29; former smoker Polymorphic VT
HF 9 49 F DCM; s/p LVAD; cardiogenic shock; HTN; BMI=20; inotrope support; AR, MR, Pulmonary 
HTN; former smoker
Dysrhythmia
HF 10 46 M NICM; acute kidney injury; cardiogenic shock; s/p ICD; pulmonary HTN; s/p IABP and 
inotropes; acute myocarditis
LBBB
AF=atrial fibrillation; AR=aortic regurgitation; BMI=body mass index; CABG=coronary artery bypass grafting; CAD=coronary artery disease; 
CKD=chronic kidney disease; COPD=chronic obstructive pulmonary disease; DCM=dilated cardiomyopathy; ECMO=extracorporeal membrane 
oxygenation; EF=ejection fraction; HF=Heart Failure; HTN=hypertension; IABP=intra-aortic balloon pump; ICD=implantable cardioverter 
defibrillator; ICH=intracerebral hemorrhage; ICM=ischemic cardiomyopathy; LAD=left anterior descending coronary artery; LBBB=left bundle 
branch block; MR=mitral regurgitation; NIDDM=non-insulin dependent diabetes mellitus; (N) STEMI=(non) ST elevation myocardial infarction; 
s/p=status post; NSVT=non-sustained ventricular tachycardia; NYHA=New York Heart Association; NICM=non-ischemic cardiomyopathy; 
NonF=Non-failing control; OSA=obstructive sleep apnea; PE=pulmonary embolism; PVD=peripheral vascular disease; RBBB=right bundle branch 
block; R/LVAD=right/left ventricular assist device; VF=ventricular fibrillation; VT=ventricular tachycardia.
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